Process Control

Analytical science has a key role to play in the development of new pharmaceutical products – from discovery, to protein analysis, to quality control.

Biopharmaceutical development is in need of a speed boost. Multi-omics could be the answer.

How a holistic approach to horseshoe crab sustainability will allow the industry to maintain stocks while protecting patients.

Nominations are now open for The Medicine Maker 2021 Innovation Awards.

Is there data demonstrating significant cost benefits from continuous biomanufacturing?

We interview Johannes Khinast, CEO and Scientific Director of the Research Center for Pharmaceutical Engineering (RCPE), Graz, Austria.

How can companies avoid the risks of HPAPI containment and handling?

Amgen developed the Multi-Attribute Method (MAM) to obtain high-fidelity understanding of the quality of its own biologics. Click to read article

Amgen has brought the Multi-Attribute Method (MAM) into the mainstream, but what’s next for this analytical workflow. Click to read article

We speak with Richard Bourne about his work on pharmaceutical processes.